Acutus Medical Inc (AFIB)

Overview News Price History Option Chain Discussions Forecast

Acutus Medical Inc stock is currently priced at $0.17, with a 24-hour trading volume of 400.61K. It has seen a -2.58% decreased in the last 24 hours and a -11.09% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $0.1753 pivot point. If it approaches the $0.1623 support level, significant changes may occur.

Acutus Medical Inc Stock (AFIB) Financials Data

Acutus Medical Inc (AFIB) Revenue 2024

AFIB reported a revenue (TTM) of $19.66 million for the quarter ending September 30, 2023, a +24.72% rise year-over-year.

Acutus Medical Inc (AFIB) Net Income 2024

AFIB net income (TTM) was -$32.79 million for the quarter ending September 30, 2023, a +61.87% increase year-over-year.

Acutus Medical Inc (AFIB) Cash Flow 2024

AFIB recorded a free cash flow (TTM) of -$60.99 million for the quarter ending September 30, 2023, a +39.31% increase year-over-year.

Acutus Medical Inc (AFIB) Earnings per Share 2024

AFIB earnings per share (TTM) was -$1.24 for the quarter ending September 30, 2023, a +60.00% growth year-over-year.

Acutus Medical Inc Stock (AFIB) Latest News

Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire Inc.

Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Why IBM Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Benzinga

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Downgrade	JP Morgan: Neutral → Underweight	Nov-15-21
Initiated	Goldman: Neutral	Oct-22-21
Upgrade	Canaccord Genuity: Hold → Buy	Jul-15-21
Downgrade	JP Morgan: Overweight → Neutral	Mar-19-21
Downgrade	William Blair: Outperform → Mkt Perform	Mar-19-21
Downgrade	BofA Securities: Buy → Neutral	Jan-14-21
Initiated	BTIG Research: Buy	Aug-31-20
Initiated	BofA Securities: Buy	Aug-31-20
Initiated	Canaccord Genuity: Hold	Aug-31-20
Initiated	JP Morgan: Overweight	Aug-31-20
Initiated	William Blair: Outperform	Aug-31-20